• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

AGYLLGKINLKALAALAKKIL details
Primary information
ID antitb_1872,
Name28314993
N-Terminal modificationTransportan
C-Terminal ModificationAGYLLGKINLKALAALAKKIL
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature21
SourceL
OriginCationic
SpeciesSynthetic
StrainConstructed from Galanin and Mastoparan proteins
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv (ATCC 27294)
Cell LineMIC = 80 μM
Inhibition ConcentrationIn vitro
Sequence2017
CytotoxicityRBC
In vivo ModelNA
Lethal Dose50% hemolysis at 38.0 ± 3.79 μM
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Streptococcus pneumoniae)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1987,
Name14656995
N-Terminal modificationTP10
C-Terminal ModificationAGYLLGKINLKALAALAKKIL
Chemical ModificationFree
Linear/CyclicAmidation
LengthNone
ChiralityLinear
Nature21
SourceL
SpeciesSynthetic
Inhibition ConcentrationMycobacterium smegmatis
In Vitro/ In vivoMycobacterium smegmatis
Cell LineMIC=6µM
Inhibition ConcentrationIn vitro
Sequence2003
CytotoxicityHeLa cells
In vivo ModelNA
Lethal DoseNA
Immune ResponceNA
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiescell wall
PMIDNA
Year of PublicationBacillus subtilis, Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhimurium, Bacillus subtilis, Candida albicans etc.
Tertiary Structure
(Technique)
Not Predicted),